Acantholytic Dyskeratosis Occurring Within an Epidermal Nevus
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Paraneoplastic Syndrome Presenting As Giant Porokeratosis in a Patient with Nasopharyngeal Cancer
Paraneoplastic Syndrome Presenting As Giant Porokeratosis in A Patient with Nasopharyngeal Cancer Fitri Azizah, Sonia Hanifati, Sri Adi Sularsito, Lili Legiawati, Shannaz Nadia Yusharyahya, Rahadi Rihatmadja Department of Dermatology and Venereology, Faculty of Medicine Universitas Indonesia / Dr. Cipto Mangunkusumo National General Hospital Keywords: porokeratosis, giant porokeratosis, paraneoplastic syndrome, nasopharyngeal Abstract: Giant porokeratosis is a rare condition in which the hyperkeratotic plaques of porokeratosis reach up to 20 cm in diameter. Porokeratosis is characterized clinically by hyperkeratotic papules or plaques with a thread-like elevated border. Although rare, porokeratosis has been reported in conjunction with malignancies suggesting a paraneoplastic nature. Associated malignancies reported were hematopoietic, hepatocellular, and cholangiocarcinoma. We report a case of giant porokeratosis in a patient with nasopharyngeal cancer responding to removal of the primary cancer by chemoradiotherapy. 1 INTRODUCTION regress completely after the treatment of malignancy, suggestive of paraneoplastic syndrome. Porokeratosis is a chronic progressive disorder of keratinization, characterized by hyperkeratotic papules or plaques surrounded by a thread-like 2 CASE elevated border corresponds to a typical histologic hallmark, the cornoid lamella . O regan, 2012) There Mr. SS, 68-year-old, was referred for evaluation of are at least six clinical variants of porokeratosis pruritic, slightly erythematous plaques with raised, recognized with known genetic disorder.1 Some hyperpigmented border of one and a half year clinical variant of porokeratosis has been reported in duration on the extensor surface of both legs. The the setting of immunosuppressive conditions, organ lesions shown minimal response to potent topical transplantation, use of systemic corticosteroids, and corticosteroids and phototherapy given during the infections, suggesting that impaired immunity may last 8 months in another hospital. -
Features of Reactive White Lesions of the Oral Mucosa
Head and Neck Pathology (2019) 13:16–24 https://doi.org/10.1007/s12105-018-0986-3 SPECIAL ISSUE: COLORS AND TEXTURES, A REVIEW OF ORAL MUCOSAL ENTITIES Frictional Keratosis, Contact Keratosis and Smokeless Tobacco Keratosis: Features of Reactive White Lesions of the Oral Mucosa Susan Müller1 Received: 21 September 2018 / Accepted: 2 November 2018 / Published online: 22 January 2019 © Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract White lesions of the oral cavity are quite common and can have a variety of etiologies, both benign and malignant. Although the vast majority of publications focus on leukoplakia and other potentially malignant lesions, most oral lesions that appear white are benign. This review will focus exclusively on reactive white oral lesions. Included in the discussion are frictional keratoses, irritant contact stomatitis, and smokeless tobacco keratoses. Leukoedema and hereditary genodermatoses that may enter in the clinical differential diagnoses of frictional keratoses including white sponge nevus and hereditary benign intraepithelial dyskeratosis will be reviewed. Many products can result in contact stomatitis. Dentrifice-related stomatitis, contact reactions to amalgam and cinnamon can cause keratotic lesions. Each of these lesions have microscopic findings that can assist in patient management. Keywords Leukoplakia · Frictional keratosis · Smokeless tobacco keratosis · Stomatitis · Leukoedema · Cinnamon Introduction white lesions including infective and non-infective causes will be discussed -
Review an Overview of the Pale and Clear Cells of the Nipple Epidermis
Histol Histopathol (2009) 24: 367-376 Histology and http://www.hh.um.es Histopathology Cellular and Molecular Biology Review An overview of the pale and clear cells of the nipple epidermis M.F. Garijo, D. Val and J.F. Val-Bernal Department of Anatomical Pathology, Marqués de Valdecilla University Hospital, Medical Faculty, University of Cantabria, Santander, Spain Summary. The stratified squamous epithelium of the exterior. In the non-lactating breast these duct openings nipple-areola complex may contain pale or clear cells are usually filled with plugs of keratin. The nipple and including: Paget’s disease cells (PDCs), Toker cells areola are covered by keratinizing stratified squamous (TCs), and so-called clear cells (CCs). Paget’s disease is epithelium similar to that seen in the epidermis an uncommon presentation of breast carcinoma. PDCs elsewhere in the body. The collecting ducts show a are large, atypical, have abundant, pale-staining double epithelial and myoepithelial lining. The cytoplasm that may contain mucin secretion vacuoles epithelium is columnar and the myoepithelial cells lie and bulky heterochromatic nuclei. They are commonly between the epithelial layer and the basal lamina. A concentrated along the basal layer and stain for EMA, cross section of the major ducts shows an irregular, CAM5.2, cytokeratin 7, and HER2/neu oncoprotein. TCs pleated or serrated outline and an investment with are bland cells with roundish and scant chromatin nuclei. muscular tissue. The areola dermis contains numerous They are found incidentally and are reactive for EMA, sebaceous glands. Some of them open directly onto the CAM5.2, and cytokeratin 7, but show negativity for surface, whereas others drain into a collecting duct or HER2/neu oncoprotein. -
Review Skin Changes Are One of the Earliest Signs of Venous a R T I C L E Hypertension
pp 11 - 19 ABSTRACT Review Skin changes are one of the earliest signs of venous A R T I C L E hypertension. Some of these changes such as venous eczema are common and easily identified whereas DERMATOLOGICAL other changes such as acroangiodermatitis are less common and more difficult to diagnose. Other vein MANIFESTATIONS OF VENOUS related and vascular disorders can also present with specific skin signs. Correct identification of these DISEASE: PART I skin changes can aid in making the right diagnosis and an appropriate plan of management. Given KUROSH PARSI, MBBS, MSc(Med), FACD, FACP the significant overlap between phlebology and Departments of Dermatology, St. Vincent’s Hospital and dermatology, it is essential for phlebologists to be Sydney Children’s Hospital familiar with skin manifestations of venous disease. Sydney Skin & Vein Clinic, This paper is the first installment in a series of 3 Bondi Junction, NSW, Australia and discusses the dermatological manifestations of venous insufficiency as well as other forms of vascular ectasias that may present in a similar Introduction fashion to venous incompetence. atients with venous disease often exhibit dermatological Pchanges. Sometimes these skin changes are the only clue to an appropriate list of differential diagnoses. Venous ulceration. Less common manifestations include pigmented insufficiency is the most common venous disease which purpuric dermatoses, and acroangiodermatitis. Superficial presents with a range of skin changes. Most people are thrombophlebitis (STP) can also occur in association with familiar with venous eczema, lipodermatosclerosis and venous incompetence but will be discussed in the second venous ulcers as manifestations of long-term venous instalment of this paper (Figure 2). -
An Update on the Biology and Management of Dyskeratosis Congenita and Related Telomere Biology Disorders
Expert Review of Hematology ISSN: 1747-4086 (Print) 1747-4094 (Online) Journal homepage: https://www.tandfonline.com/loi/ierr20 An update on the biology and management of dyskeratosis congenita and related telomere biology disorders Marena R. Niewisch & Sharon A. Savage To cite this article: Marena R. Niewisch & Sharon A. Savage (2019) An update on the biology and management of dyskeratosis congenita and related telomere biology disorders, Expert Review of Hematology, 12:12, 1037-1052, DOI: 10.1080/17474086.2019.1662720 To link to this article: https://doi.org/10.1080/17474086.2019.1662720 Accepted author version posted online: 03 Sep 2019. Published online: 10 Sep 2019. Submit your article to this journal Article views: 146 View related articles View Crossmark data Citing articles: 1 View citing articles Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=ierr20 EXPERT REVIEW OF HEMATOLOGY 2019, VOL. 12, NO. 12, 1037–1052 https://doi.org/10.1080/17474086.2019.1662720 REVIEW An update on the biology and management of dyskeratosis congenita and related telomere biology disorders Marena R. Niewisch and Sharon A. Savage Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA ABSTRACT ARTICLE HISTORY Introduction: Telomere biology disorders (TBDs) encompass a group of illnesses caused by germline Received 14 June 2019 mutations in genes regulating telomere maintenance, resulting in very short telomeres. Possible TBD Accepted 29 August 2019 manifestations range from complex multisystem disorders with onset in childhood such as dyskeratosis KEYWORDS congenita (DC), Hoyeraal-Hreidarsson syndrome, Revesz syndrome and Coats plus to adults presenting Telomere; dyskeratosis with one or two DC-related features. -
Progressive Widespread Warty Skin Growths
DERMATOPATHOLOGY DIAGNOSIS Progressive Widespread Warty Skin Growths Patrick M. Kupiec, BS; Eric W. Hossler, MD Eligible for 1 MOC SA Credit From the ABD This Dermatopathology Diagnosis article in our print edition is eligible for 1 self-assessment credit for Maintenance of Certification from the American Board of Dermatology (ABD). After completing this activity, diplomates can visit the ABD website (http://www.abderm.org) to self-report the credits under the activity title “Cutis Dermatopathology Diagnosis.” You may report the credit after each activity is completed or after accumu- lating multiple credits. A 33-year-old man presented with progres- sive widespread warty skin growths that had been present copysince 6 years of age. Physical examination revealed numerous verrucous papules on the face and neck along with Figure 1. H&E, original magnification ×40. Figure 2. H&E, original magnification ×40. verrucous, tan-pink papules and plaques diffuselynot scattered on the trunk, arms, and legs. A biopsy of a lesion on the neck Dowas performed. H&E, original magnification ×200. The best diagnosisCUTIS is: a. condyloma acuminatum b. epidermodysplasia verruciformis c. herpesvirus infection d. molluscum contagiosum e. verruca vulgaris PLEASE TURN TO PAGE 99 FOR DERMATOPATHOLOGY DIAGNOSIS DISCUSSION Mr. Kupiec is from the State University of New York (SUNY) Upstate Medical University, Syracuse. Dr. Hossler is from the Departments of Dermatology and Pathology, Geisinger Medical Center, Danville, Pennsylvania. The authors report no conflict of interest. Correspondence: Patrick M. Kupiec, BS, 50 Presidential Plaza, Syracuse, NY 13202 ([email protected]). 82 CUTIS® WWW.CUTIS.COM Copyright Cutis 2017. No part of this publication may be reproduced, stored, or transmitted without the prior written permission of the Publisher. -
Vulvar Disease: Overview of Diagnosis and Management for College Aged Women
Vulvar Disease: Overview of Diagnosis and Management for College Aged Women Lynette J. Margesson MD FRCPC ACHA 2013 Annual Meeting, May 30, 2013 No Conflicts of interest Lynette Margesson MD Little evidence based treatment Most information is from small open trials and clinical experience. Most treatment discussed is “off-label” Why Do Vulvar Disease ? Not taught Not a priority Takes Time Still an area if taboo VULVAR CARE IS COMMONLY UNAVAILABLE For women this is devastating Results of Poor Vulvar Care Women : - suffer with undiagnosed symptoms - waste millions of dollars on anti-yeasts - hide and scratch - endure vulvar pain and dyspareunia - are desperate for help VULVA ! What is that? Down there? Vulvar Education Lets eliminate the “Down there” generation Use diagrams and handouts See www.issvd.org - patient education Recognize Normal Anatomy Normal vulvar anatomy Age Race Hormones determine structure - Size & shape - Pigmentation -Hair growth History A good,detailed,accurate history All previous treatment Response to treatment All medications, prescribed and over-the-counter TAKE TIME TO LISTEN Genital History in Women Limited by: embarrassment lack of knowledge social taboos Examination Tips Proper visualization - light + magnification Proper lighting – bright, but no glare Erythema can be normal Examine rest of skin, e.g. mouth, scalp and nails Many vulvar diseases scar, not just lichen sclerosus Special Anatomic Variations Sebaceous hyperplasia ectopic sebaceous glands Vulvar papillomatosis Pre-anesthesia – BIOPSY use a topical -
Brown Papules and a Plaque on the Calf
PHOTO CHALLENGE CLOSE ENCOUNTERS WITH THE ENVIRONMENT Brown Papules and a Plaque on the Calf Jin A. Kim, MD; Ji Hyun Lee, MD, PhD; Jun Young Lee, MD, PhD; Young Min Park, MD, PhD copy not Do A 61-year-old man presented with a cluster of asymptomatic brown papules and a plaque on the left calf of several years’ duration. The lesion consisted of multiple, dark brown, hyperkeratotic papules on a well-demarcated light brown flat plaque. The patient reported no increase in the size or number of lesions. He did not have a history of trauma or a per- sonal or family history of skin cancer. CUTIS What’s the diagnosis? a. agminated lentiginosis b. irritated seborrheic keratosis c. lentigo maligna melanoma d. speckled lentiginous nevus e. verruca plana From the Department of Dermatology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul. The authors report no conflict of interest. Correspondence: Young Min Park, MD, PhD, Department of Dermatology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-Gu, Seoul, South Korea ([email protected]). WWW.CUTIS.COM VOLUME 97, JUNE 2016 E17 Copyright Cutis 2016. No part of this publication may be reproduced, stored, or transmitted without the prior written permission of the Publisher. Photo Challenge Discussion The Diagnosis: Irritated Seborrheic Keratosis iopsies of one of the protruding papules and the The histology of SK shows monotonous basaloid underlying plaque were performed. The speci- tumor cells without atypia. It generally is com- Bmen from the papule showed hyperkeratosis, prised of focal acanthosis and papillomatosis with acanthosis, papillomatosis, and a flattened dermoepi- a sharp flat base. -
Cutaneous Adverse Reaction to Infliximab: Report of Psoriasis Developing in 3 Patients
THERAPEUTICS FOR THE CLINICIAN Cutaneous Adverse Reaction to Infliximab: Report of Psoriasis Developing in 3 Patients Gregg A. Severs, DO; Tara H. Lawlor, DO; Stephen M. Purcell, DO; Donald J. Adler, DO; Robert Thompson, MD Infliximab is a chimeric immunoglobulin G1k nfliximab is a chimeric immunoglobulin monoclonal antibody against tumor necrosis fac- G1k monoclonal antibody (75% human and tor a (TNF-a), a proinflammatory cytokine that I 25% mouse origin) against tumor necrosis participates in both normal immune function and factor a (TNF-a). It neutralizes the biologic activity the pathogenesis of many autoimmune disorders. of TNF-a by directly binding to soluble and trans- Treatment with infliximab reduces the biologic membrane TNF-a molecules in the plasma and activities of TNF-a and thus is indicated in the on the surface of macrophages and T cells in dis- treatment of rheumatoid arthritis, Crohn disease, eased tissue. The binding destroys these TNF-a ankylosing spondylitis, psoriatic arthritis, plaque molecules via antibody-dependent cellular toxicity psoriasis, and ulcerative colitis. and complement-dependent cytotoxic mechanisms. To our knowledge, there have been 13 case Thus, infliximab decreases the actions of TNF-a, reports of new-onset psoriasis, psoriasiform der- which include induction of proinflammatory cyto- matitis, and palmoplantar pustular psoriasis that kines such as interleukins (IL) 1 and 6; enhancement developed during treatment with infliximab. We of leukocyte migration by increasing endothelial layer report 3 additional cases of biopsy-proven new- permeability and expression of adhesion molecules onset psoriasis that developed while the patients by endothelial cells and leukocytes; activation of underwent treatment with infliximab for inflamma- neutrophil and eosinophil functional activity; induc- tory bowel disease. -
Incidental Focal Acantholytic Dyskeratosis in the Setting of Rosacea
Letter to the Editor http://dx.doi.org/10.5021/ad.2013.25.4.518 Incidental Focal Acantholytic Dyskeratosis in the Setting of Rosacea Sang-Yeon Park, Hae Jin Lee, Jae Yong Shin, Sung Ku Ahn Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Korea Dear Editor: direct immunofluorescence (Fig. 2). In the serial sections, Focal acantholytic dyskeratosis (FAD) was first described we observe the same findings. Differential diagnosis for by Ackerman1 in 1972 as a distinct histopathological pat- the possibility of polymorphous light eruption, systemic tern associated with various cutaneous conditions, and lupus erythematosus, contact dermatitis, and dermatitis with classic histopathological findings including supra- artefacta should be considered. But given these clinical basal clefting, hyperkeratosis and parakeratosis, and the and histopathological features, a diagnosis of rosacea with presence of acantholytic and dyskeratotic cells at the FAD was reached. The patient was then admitted to epidermis. While FAD can be observed in many various hospital for treatment with doxycycline 100 mg and cutaneous lesions including benign and/or malignant antihistamines. After one week, the lesions had remarka- epithelial lesions, fibrohistiocytic lesions, inflammatory bly improved. The patient was then discharged, and lesions, melanocytic and/or follicular lesions2-4. These continued on the same therapeutic regimen for an histopathological findings may also extend into the additional month, bythe time all lesions were nearly surrounding tissues, which often appear to be clinically resolved. normal. A 42-year-old woman was presented to our To date, the etiology of FAD has been attributed to department with multiple erythematous pruritic papules numerous sources including hormones, viral infection, and tiny vesicles on her face. -
UC Davis Dermatology Online Journal
UC Davis Dermatology Online Journal Title Multiple acantholytic dyskeratotic acanthomas in a liver-transplant recipient Permalink https://escholarship.org/uc/item/24v5t78z Journal Dermatology Online Journal, 25(4) Authors Kanitakis, Jean Gouillon, Laurie Jullien, Denis et al. Publication Date 2019 DOI 10.5070/D3254043575 License https://creativecommons.org/licenses/by-nc-nd/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Volume 25 Number 4| April 2019| Dermatology Online Journal || Case Presentation 25(4):6 Multiple acantholytic dyskeratotic acanthomas in a liver- transplant recipient Jean Kanitakis1,2, Laurie Gouillon1, Denis Jullien1, Emilie Ducroux1 Affiliations: 1Department of Dermatology, Edouard Herriot Hospital Group, Lyon, France, 2Department of Pathology, Centre Hospitalier Lyon Sud, Pierre Bénite, France Corresponding Author: Jean Kanitakis, Department of Dermatology, Edouard Herriot Hospital Group (Pavillion R), 69437 Lyon cedex 03, France, Tel: 33-472110301, Email: [email protected] (0.5mg/d) and prednisolone (5mg/d). He had Abstract recently developed end-stage renal disease and was Acantholytic dyskeratotic acanthoma is a rare variant undergoing hemodialysis. His post-transplant of epidermal acanthoma characterized pathologically medical history was significant for two melanomas by the presence of acantholysis and dyskeratosis. (one in situ on the abdomen diagnosed at the age of Few cases have been reported until now, one of them 61 years and a superficial spreading melanoma in a heart-transplant patient. We present here a new 2.4mm Breslow thickness of the dorsum of the foot case of this rare lesion that developed in a liver- diagnosed ten years later), a squamous cell transplant patient and review the salient features of this uncommon condition. -
Boards Fodder Disorders of Dyschromia (Hypo- and Hyperpigmentation) by Parin Pearl Rimtepathip, MD, and Janna Mieko Vassantachart, MD
boards fodder Disorders of dyschromia (hypo- and hyperpigmentation) by Parin Pearl Rimtepathip, MD, and Janna Mieko Vassantachart, MD Genetic conditions Gene Disorder Pathophysiology Clinical Features (Unique Features) Mutation Dyskeratosis XLR (MC): Reduced telomerase activ- Male > Female. Bone marrow failure up to Congenita DKC 1 ity and abnormally short- 90% (increase risk of hematopoietic malig- (Zinsser-Engman- ened telomeres chro- nancies) + triad of abnormal skin pigmenta- Cole syndrome) AD: TERT, mosomal instability/cellu- tion (poikilodermatous patches of face/neck/ TERC lar replication dysfunction upper torso), onychodystrophy, premalignant oral leukoplakia (vs benign oral leukoplakia in Pachyonychia Congenita type I) Dyschromatosis AD: ADAR Heterozygous mutations in Presents by 6-years-old with hyper/hypopig- Symmetrica (SDAR the gene encodes an RNA mented macules restricted to sun-exposed Hereditaria gene) specific adenosine deami- skin on the dorsal aspects of bilateral (Reticulate nase extremities and face Acropigmentation of Dohi) Naegeli- AD: Location of expression of Allelic to DPR. Brown gray reticulated hyper- Franceschetti- Keratin keratin 14 - Basal kerati- pigmentation typically localized to abdomen, Jadassohn 14 nocytes develops around age 2 and improves after Syndrome (NFJS) puberty. Other findings: PPK + adermato- glyphia (no finger prints) + dental anomalies including early loss of teeth (not seen in DPR) + hypohidrosis + onychodystrophy Dermatopathia AD: Location of expression of Allelic to NFJS. Unique features: diffuse non- Pigmentosa Keratin keratin 14 - Basal kerati- scarring alopecia (not seen in NFJS) + ony- Reticularis (DPR) 14 nocytes chodystrophy + adermatoglyphia + persistent reticulated hyperpigmentation of torso and proximal UE + No dental anomalies Dyschromatosis AD/AR: Mutation in ATP bind- Japanese. Torso predominant with mottled Universalis ABCB6 ing cassette subfamily B, appearance, nail dystrophy, and pterygium.